Evidence map›Paper›PMID 41599636›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

FAPI Tracer

Victoria Weissenböck, Michaela Schlederer, Latifa Bakiri, Johanna Schaffenrath, Erwin F Wagner, Frank Rösch, Marcus Hacker, Lukas Kenner, Cécile Philippe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Victoria WeissenböckDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Michaela SchledererDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Latifa BakiriDepartment of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-6300-2420
Johanna SchaffenrathGenes and Disease Laboratory, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-1689-1648
Erwin F WagnerGenes and Disease Laboratory, Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Frank RöschInstitute of Nuclear Chemistry, Johannes Gutenberg University Mainz, 55128 Mainz, Germany.
Marcus HackerDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-4222-4083
Lukas KennerDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-2184-1338
Cécile PhilippeDepartment of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7203-7174

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bleomycinFAPfibrosisfra-2PET

Identifiers

PMID41599636
PMCPMC12844954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.